ATE493125T1 - Carbamatverbindungen zur behandlung von schmerz - Google Patents

Carbamatverbindungen zur behandlung von schmerz

Info

Publication number
ATE493125T1
ATE493125T1 AT02723222T AT02723222T ATE493125T1 AT E493125 T1 ATE493125 T1 AT E493125T1 AT 02723222 T AT02723222 T AT 02723222T AT 02723222 T AT02723222 T AT 02723222T AT E493125 T1 ATE493125 T1 AT E493125T1
Authority
AT
Austria
Prior art keywords
carbamat
compounds
treating pain
pain
treating
Prior art date
Application number
AT02723222T
Other languages
English (en)
Inventor
Carlos R Plata-Salaman
Boyu Zhao
Roy E Twyman
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Application granted granted Critical
Publication of ATE493125T1 publication Critical patent/ATE493125T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/325Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/27Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT02723222T 2001-02-27 2002-02-21 Carbamatverbindungen zur behandlung von schmerz ATE493125T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US27188801P 2001-02-27 2001-02-27
PCT/US2002/005421 WO2002067922A1 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in the treatment of pain

Publications (1)

Publication Number Publication Date
ATE493125T1 true ATE493125T1 (de) 2011-01-15

Family

ID=23037511

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02723222T ATE493125T1 (de) 2001-02-27 2002-02-21 Carbamatverbindungen zur behandlung von schmerz

Country Status (28)

Country Link
US (1) US6815464B2 (de)
EP (1) EP1404312B1 (de)
JP (1) JP4276838B2 (de)
KR (1) KR100906315B1 (de)
CN (1) CN1849116A (de)
AR (1) AR033427A1 (de)
AT (1) ATE493125T1 (de)
AU (1) AU2002254015B2 (de)
BR (1) BR0207673A (de)
CA (1) CA2439274C (de)
CY (1) CY1111349T1 (de)
CZ (1) CZ20032298A3 (de)
DE (1) DE60238765D1 (de)
DK (1) DK1404312T3 (de)
ES (1) ES2356617T3 (de)
HU (1) HUP0303236A3 (de)
IL (1) IL157593A0 (de)
MX (1) MXPA03007721A (de)
MY (1) MY129312A (de)
NO (1) NO20033804L (de)
NZ (1) NZ527994A (de)
PL (1) PL364647A1 (de)
PT (1) PT1404312E (de)
RS (1) RS67603A (de)
RU (1) RU2283106C2 (de)
TW (1) TWI304735B (de)
WO (1) WO2002067922A1 (de)
ZA (1) ZA200307475B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2454049A1 (en) * 2001-07-16 2003-01-30 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neuropathic pain
EP1998781A2 (de) * 2006-03-24 2008-12-10 Wyeth a Corporation of the State of Delaware Schmerzbehandlung
WO2010071865A1 (en) 2008-12-19 2010-06-24 Nuon Therapeutics, Inc. Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
US20100160351A1 (en) * 2008-12-19 2010-06-24 Nuon Therapeutics, Inc. Pharmaceutical compositions and methods for treating hyperuricemia and related disorders
WO2011032175A1 (en) 2009-09-14 2011-03-17 Nuon Therapeutics, Inc. Combination formulations of tranilast and allopurinol and methods related thereto
AU2010316172B2 (en) * 2009-11-06 2015-11-12 Sk Biopharmaceuticals Co., Ltd. Methods for treating fibromyalgia syndrome
MX2012005258A (es) 2009-11-06 2012-06-19 Sk Biopharmaceuticals Co Ltd El uso de un compuesto de carbamoilo para el tratamiento del trastorno de deficit de atencion/hiperactividad.
US8623913B2 (en) 2010-06-30 2014-01-07 Sk Biopharmaceuticals Co., Ltd. Methods for treating restless legs syndrome
US9610274B2 (en) 2010-06-30 2017-04-04 Sk Biopharmaceuticals Co., Ltd. Methods for treating bipolar disorder
US9018253B2 (en) 2010-07-02 2015-04-28 Bio-Pharm Solutions Co., Ltd. Phenylcarbamate compound and muscle relaxant containing the same
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
CN102266317A (zh) * 2011-06-24 2011-12-07 中国人民解放军第三军医大学 丙戊酸及其衍生物的应用
JP2015504054A (ja) 2011-12-27 2015-02-05 バイオ−ファーム ソリューションズ カンパニー リミテッド 多発性硬化症の治療または予防に使用されるフェニルカルバメート化合物
CN109939092B (zh) 2013-03-12 2022-03-22 比皮艾思药物研发有限公司 用于预防或治疗小儿癫痫和癫痫相关综合征的苯基氨基甲酸酯化合物
KR102421013B1 (ko) * 2016-05-19 2022-07-14 에스케이바이오팜 주식회사 삼차신경통을 예방 또는 치료하기 위한 카바메이트 화합물의 용도

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3278380A (en) * 1962-02-06 1966-10-11 Armour Pharma Methods of calming employing diphenyl hydroxy carbamate compounds
US3265728A (en) 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
US5698588A (en) 1996-01-16 1997-12-16 Yukong Limited Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
GB2340074A (en) * 1998-08-01 2000-02-16 Max Imaging Systems Limited Printing process
SK1962003A3 (en) 2000-07-21 2004-08-03 Ortho Mcneil Pharm Inc Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain

Also Published As

Publication number Publication date
JP2004523553A (ja) 2004-08-05
ES2356617T3 (es) 2011-04-11
EP1404312B1 (de) 2010-12-29
CZ20032298A3 (cs) 2004-08-18
NO20033804D0 (no) 2003-08-26
PL364647A1 (en) 2004-12-13
KR100906315B1 (ko) 2009-07-07
EP1404312A1 (de) 2004-04-07
CA2439274A1 (en) 2002-09-06
HUP0303236A3 (en) 2012-07-30
HUP0303236A2 (hu) 2004-01-28
BR0207673A (pt) 2004-12-28
PT1404312E (pt) 2011-02-01
AU2002254015B2 (en) 2006-08-24
CN1849116A (zh) 2006-10-18
US6815464B2 (en) 2004-11-09
RU2283106C2 (ru) 2006-09-10
JP4276838B2 (ja) 2009-06-10
WO2002067922A1 (en) 2002-09-06
MY129312A (en) 2007-03-30
NZ527994A (en) 2005-11-25
IL157593A0 (en) 2004-03-28
MXPA03007721A (es) 2004-11-12
TWI304735B (en) 2009-01-01
CA2439274C (en) 2011-04-05
RU2003128984A (ru) 2005-03-20
KR20030076711A (ko) 2003-09-26
US20020156127A1 (en) 2002-10-24
RS67603A (en) 2007-02-05
NO20033804L (no) 2003-09-30
ZA200307475B (en) 2005-01-03
CY1111349T1 (el) 2015-08-05
DK1404312T3 (da) 2011-03-14
AR033427A1 (es) 2003-12-17
DE60238765D1 (de) 2011-02-10

Similar Documents

Publication Publication Date Title
DE50009504D1 (de) Verwendung von retigabin zur behandlung von neuropathischen schmerzen
DE60138129D1 (de) Apparat zur behandlung von zähnen
ATE515261T1 (de) Zusammensetzungen zur behandlung von diabetes
ATE275145T1 (de) Chinazolinderivate zur behandlung von tumoren
DE60020171D1 (de) Gerät zur behandlung von bandscheiben
DE60325770D1 (de) Verwendung von rimexolon zur behandlung von augentrockenheit
ATE410430T1 (de) 2,3-dihydro-6-nitroimidazoä2,1- büoxazolverbindungen zur behandlung von tuberkulose
DE60234760D1 (de) Phenylindole zur behandlung von hiv
DE60019158D1 (de) Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien
DE60313021D1 (de) 4-tetrazolyl-4-phenylpiperidindervate zur schmerzbehandlung
DE60136477D1 (de) Retinoide zur behandlung von emphysem
DE60211740D1 (de) Zusammensetzung zur saatgutbehandlung
DE69925865D1 (de) 4-(aminomethyl)-piperidinbenzamide zur behandlung von gastrointestinalen störungen
DE60233186D1 (de) Verbessertes System zur Behandlung von Elementarschwefel-Rückständen
ATE361745T1 (de) Carbamatverbindungen zur vorbeugung oder behandlung von neurodegenerativen störungen
DE60014928D1 (de) Retinoide zur behandlung von emphysem
ATE493125T1 (de) Carbamatverbindungen zur behandlung von schmerz
ATE263777T1 (de) Zusammensetzungen zur behandlung von entzündungsreaktionen
DE60221670D1 (de) Carbamatverbindungen zur vorbeugung und behandlung von bewegungsstörungen
DE60223688D1 (de) Verfahren zur behandlung von multiplem myelom
DE69943089D1 (de) Methode zur behandlung von staphylokokkeninfektionen
DE602004019576D1 (de) Zur behandlung von schmerzen geeignete piperazine
DE60033020D1 (de) Gerät zur behandlung von zahnkaries
DE60214355D1 (de) Exemestan zur behandlung von hormonabhängigen störungen
DE50105735D1 (de) Chlorzoxazon zur behandlung von psoriasis

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1404312

Country of ref document: EP